For instance, in non-small cell lung cancer (NSCLC), only a small minority of tumors co-express both PD-L1 and SIGLEC-15; one analysis reported the co-expression rate to be as low as ~3% [20]. Here, CD274 is linked to non-small cell lung carcinoma.